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The aims of the present study were to compare the levels of mRNA and protein expression of matrix metalloproteinase (MMP)-1, -
3, -8 and -9 in human cervical tissue in preterm and term labor as well as not in labor and to determine if corticotropin-releasing
hormone (CRH) has an effect on MMP-1, -3 and interleukin (IL)-8 secretion in both preterm and term cervical ﬁbroblasts. Cer-
vical biopsies were taken from 60 women: 18 at preterm labor, 7 at preterm not in labor, 18 at term labor and 17 at term not in
labor. ELISA and Immulite were used for protein and real-time RT–PCR for mRNA analysis. Cervical ﬁbroblast cultures were
incubated for 18 h with different CRH concentrations (10
213–10
26 M). The mRNA expression of MMP-1, -3 and -9 was higher in
laboring groups compared with term not in labor. Protein levels of MMP-8 and -9 were higher in term in labor group compared
with non-laboring groups. There were no signiﬁcant differences in mRNA and protein expression between the preterm and
respective term control groups. CRH signiﬁcantly increased secretion of IL-8 in preterm and term cervical ﬁbroblasts compared
with controls. The secretion of IL-8 and MMP-1 was signiﬁcantly higher and MMP-3 secretion lower in preterm cervical ﬁbro-
blasts. In conclusion, cervical ripening at preterm seems to be a similar inﬂammatory process as at term with CRH involved.
However, preterm and term cervical ﬁbroblasts might have different phenotypes based on different secretion patterns of IL-8,
MMP-1 and MMP-3.
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Introduction
Preterm birth (PTB) is the leading cause of neonatal morbidity and
mortality (Saigal and Doyle, 2008). Despite the several strategies
for treatment, the frequency of PTB has not changed signiﬁcantly
during the past three decades and the mechanisms underlying the
initiation of both preterm and term labor remain largely unknown
(Challis et al., 2000; Hertelendy and Zakar, 2004; Iams et al.,
2008). Uterine contractions must be coordinated with a softening of
the cervix for a successful delivery. Cervical softening involves inten-
sive remodeling of the extracellular matrix (ECM), with extensive
changes in concentration and composition of collagens (Uldbjerg
et al., 1983; Ekman et al., 1986) and proteoglycans (Norman et al.,
1993; Westergren-Thorsson et al., 1998). Cytokines and several
other mediators, including estrogen, progesterone, prostaglandins
and nitric oxide, participate in the remodeling of ECM and ripening
of the human cervix (Stjernholm et al., 1997; Abelin Tornblom
et al., 2002; Hertelendy and Zakar, 2004; Tornblom et al., 2005b).
This process can be regarded as an inﬂammatory reaction associated
with elevated levels of cytokines at the time of both preterm
and time labor (Sennstrom et al., 2000; Tornblom et al., 2005a).
Interleukin (IL)-6 and IL-8 increase at least 100-fold at term labor
(Sennstrom et al., 2000). IL-8 promotes recruitment and activation
of neutrophils, which in turn secrete proteolytic enzymes, such as
matrix metalloproteinase (MMP)-8 and MMP-9 (Osmers et al.,
1995; Stygar et al., 2002). The MMPs play a central role in the degra-
dation of ECM components. The levels of MMPs in the cervix, lower
uterine segment, amniotic ﬂuid, fetal membranes and maternal plasma
increase at labor time (Tu et al., 1998; Winkler et al., 1999; Stygar
et al., 2002; Sennstromet al., 2003; Weiss et al.,2007). Polymorphism
in MMP-1 and MMP-9 genes has been shown to be associated with
preterm premature rupture of membranes (Ferrand et al., 2002;
Fujimoto et al., 2002).
Corticotropin-releasing hormone (CRH) is the principal regulator of
the hypothalamic–pituitary–adrenal (HPA) axis. The HPA axis has
been of interest in connection with labor since Liggins induced prema-
ture parturition in sheep with corticotropin and cortisol infusion
(Liggins, 1968). CRH is produced by fetomaternal tissues and secreted
into the maternal circulation, so that during pregnancy the maternal
plasma levels of this hormone increase, while the corresponding
binding protein (CRH-BP) levels are reduced (Linton et al., 1993;
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signiﬁcantly elevated plasma levels of CRH and lower CRH-BP levels
(Hobel et al., 1999).
CRH, CRH-BP and the receptors for CRH, CRH-R1 and CRH-R2
are expressed in human placenta, deciduas, fetal membranes, endome-
trium and myometrium (Kalantaridou et al., 2007). Furthermore, CRH
increases MMP-9 protein secretion by cultured cells from placenta and
fetal membranes (Li and Challis, 2005). In our previous study we have
localized CRH, CRH-BP, CRH-R1 and CRH-R2 in the cervix, which
suggested that the cervix may be a target for CRH action (Klimavi-
ciute et al., 2006). Therefore, our present aim was to determine if
CRH has an effect on the secretion of IL-8, MMP-1 and MMP-3 in
both preterm and term cervical ﬁbroblasts. Furthermore, our aim
was to compare the levels of mRNA and protein expression of
MMP-1, MMP-3, MMP-8 and MMP-9 in human cervical tissue in
preterm and term labor as well as not in labor.
Materials and Methods
Patients
A total of 51 women were included in the study for the analysis of MMP
expression. Two preterm groups consisted of 14 women undergoing preterm
labor (PTL) and 7 women delivered preterm by Caesarean section prior to the
onset of labor (PTnotL). Preterm delivery was deﬁned as delivery before the
37thweek ofgestation. Two controltermgroups included 13women undergoing
normal term labor (TL) and 17 women at term not in labor delivered by elective
Caesarean section (TnotL). The labor groups (PTL and TL) were in active labor
and demonstrated a ripe cervix, with dilatation more than 4 cm. They were either
delivered vaginally or by emergency Caesarean section due to malpresentation
(at preterm and at term) or due to threatening fetal asphyxia (at term). In all
patients delivered by Caesarean section, the assessment of cervical dilatation
was established immediately before surgery. Women not in labor (PTnotL and
TnotL) had unripe cervices (with a Bishop score of ,5 points) and were deliv-
ered by Caesarean section prior to the onset of labor. The preterm indications
were suspected placental abruption or intrauterine growth retardation and the
term indications were breech presentation, humanitarian or disproportion.
Cervical biopsies from an additional nine women (four PTL and ﬁve TL)
were used for the cultures of cervical ﬁbroblasts.
Noneofthewomenincludedinthestudysufferedfrompre-eclampsia,diabetes
or other systemic disease, nor did any of our subjects demonstrate clinical signs
of infection in connection with parturition or during the post-partal period.
There were no signiﬁcant differences between these groups of women with
respect to maternal age, parity, previous PTBs and Caesarean sections. More-
over, there was no signiﬁcant difference in gestational age between the groups
PTL and PTnotL or TL and TnotL. Clinical data on the women is presented in
Table I.
Prior to the performance of this study, the approval of the local Ethics Com-
mittee of Karolinska Institute (Ref. no. 97-089 and 04-637/4) and the informed
consent of each subject was received.
Sampling procedure
Immediately following vaginal delivery and Caesarean section, a biopsy was
taken transvaginally (at the 12 o’clock position) from the anterior cervical lip
with scissors and tweezers. The samples to be utilized for mRNA or protein
analysis were immediately frozen and stored thereafter at 2708C. The biopsies
to be used for the cultures of cervical ﬁbroblasts were immersed in GIBCOTM
RPMI 1640 Medium (Invitrogen Corporation, Paisly, Scotland, UK) and stored
in refrigerator for a maximum of 24 h before proceeding to the establishment of
cell cultures.
The limited amount of tissue available from each woman did not allow
performance of all of the different analyses on each individual sample.
Tissue homogenization and extraction of RNA
Tissue homogenization was carried out by the help of a dismembranation
apparatus (Retsch KG, Haan, Germany) and followed by either RNA or
protein extraction.
Total RNA was extracted using the Trizol reagent(Invitrogen, Carlsbad, CA,
USA) as described previously (Tornblom et al., 2005a).
Treatment with DNase and reverse transcription
The concentration of total RNA obtained was determined on the basis of the
OD260 using a DU64
w spectrophotometer (Beckman, Palo Alto, CA, USA)
and only samples exhibiting an OD260/OD280 ratio higher than 1.5 were used
for RT–PCR. 2 mg total RNA, pre-treated with 2 ml RQ1 RNase-Free DNase
(Promega, Madison, WI, USA), was used for RT reaction, which was per-
formed using SuperScriptTM RNase H
2 Reverse Transcriptase (Invitrogen)
as described elsewhere (Tornblom et al., 2005a). The cDNA was stored at
2708C prior to use.
Real-time RT–PCR
The levels of mRNA encoding MMP-1, MMP-3, MMP-8 and MMP-9 were
quantiﬁed by real-time RT–PCR employing the Applied Biosystems 7300
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). All
determinations were performed in triplicate in Taqman Universal PCR
Master Mix (Applied Biosystems) on 96-well optical PCR plates. Appropriate
primers and probes were purchased from commercially available Taqman
w
gene expression assays (Applied Biosystems). Two different Taqman
w gene
expression assays were used for mRNA detection of MMP-8. Primers and
probes in these two assays detect different sequences. The second assay was
used to conﬁrm unexpected results from the ﬁrst assay. Assay IDs and
GenBank accession numbers are presented in Table II. For each reaction,
5 ml diluted cDNA (corresponding to 20 ng total RNA), 12.5 ml Universal
Table I. Clinical data on women included in the study.
Parameter mRNA and protein analysis in the cervical tissue Cervical ﬁbroblasts
Preterm in labor
(PTL)
Term in labor
(TL)
Preterm not in labor
(PTnotL)
Term not in labor
(TnotL)
PTL TL
n 14 13 7 17 4 5
Age 28 (18–37) 28 (20–36) 32 (27–35) 30 (25–39) 31 (30–36) 29 (23–31)
Parity 1 (0–3) 1 (0–2) 1 (0–2) 0 (0–3) 0 (0–1) 1 (0–2)
Previous preterm births in the
group
10 1 2 0 0
Previous Caesarian section 0 (0–1) 0 (0–1) 0 (0–0) 0 (0–2) 0 0
Previous Caesarian sections in
the group
32 0 4 0 0
Gestational age in fgw
a 33 (26–36) 40 (37–42) 27 (26–36) 38 (37–39) 30 (25–35) 40 (38–40)
Gestational age in days 238 (184–255) 283 (259–294) 193 (183–256) 270 (260–278) 214 (176–247) 280 (272–282)
Treatment with corticosteroids 4 0 4 0 2 0
Data are presented as median (range) if not otherwise stated.
afull gestational weeks.
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Real-time PCR reaction was carried out according to a standard manufacturer
protocol involving 40–45 cycles of denaturation–annealing. The threshold
cycles (CT), at which an increase in reporter ﬂuorescence above the baseline
signal could ﬁrst be detected, were determined. 18s and b-actin were used as
endogenous controls. The geometric mean of two endogenous controls was
used for normalization of the mRNA levels for the gene of interest
(Vandesompele et al., 2002). The geometric mean was subtracted from the
respective gene, giving the DCT as a reﬂection of the relative mRNA
expression. Since a higher DCT corresponds to a lower mRNA expression,
the DCT values are presented inverted as 100/DCT. Serial dilutions of placental
cDNA made from purchased total RNA (Ambion, Austin, TX, USA) were used
for validation of the experiment.
Protein extraction
Following the tissue homogenization, 1 ml of phosphate-buffered saline (PBS),
including 0.01% Triton X-100, was added. After centrifugation at 10 000g,4 8C
for 10 min, supernatant was retrieved and stored in aliquots at 2708C until
analyzed.
Total protein concentration was determined using a BCA protein assay kit
(Pierce Chemical Co., Rockford, IL, USA) according to the manufacturer’s
instructions.
Determination of the protein levels of MMPs
The concentrations of all MMPs in the supernatants were determined
employing Amersham Matrix metalloproteinase Biotrak ELISA system (GE
Healthcare, Amersham Place, Buckinghamshire, UK) according to the manu-
facturer’s instructions. The assays detect the levels of total MMP-1, -3, -8
and -9. The results were interpolated from the standard reference curve
provided with each kit. The sensitivity of kits was 1.7 ng/ml for MMP-1,
2.35 ng/ml for MMP-3, 0.032 ng/ml for MMP-8 and 0.6 ng/ml for MMP-9.
The concentrations of MMP-1, -3, -8 and -9 were normalized against the
total protein concentration.
Cell culture establishment
Cervical ﬁbroblasts were established from the cervical biopsies obtained
directly after vaginal delivery. The biopsies were rinsed in Earle’s Minimal
Essential Medium (EMEM), cut into pieces of 1m m
3, and allowed to
adhere to the bottom of the culture chamber at 378C and 5% CO2, for 4 h
before addition of EMEM with penicillin (1%), streptomycin (1%), glutamine
(1%) and donor calf serum (10%).Explants were incubated for 2–3 weeks until
conﬂuent ﬁbroblast cultures were obtained. Sub-cultures of cells were done by
trypsinization according to standard procedures giving rise to two separate but
identical preparations for further experiments. All experiments were done with
cells in passages between 3 and 5.
Phenotype of the ﬁbroblasts was identiﬁed morphologically and employing
three ﬁbroblast markers: vimentin (sc53464, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-ﬁbroblast surface protein antibody 1B10 (F4771,
Sigma, St Louis, Missouri, USA) and prolyl-4-hydroxylase beta (AF0910-1,
Acris Antibodies GmbH, Hiddenhausen, Germany). The cells were ﬁxed
with 4% formaldehyde for 10 min, permeabilized with 0.2% Triton X-100 in
PBS for 10 min, and unspeciﬁc binding was blocked with a 2% solution of
bovine serum albumin in PBS for 1 h. The cells were then incubated with
the primary antibodies (1:100 in blocking buffer) overnight at 48C. Alexa
Fluor 488-conjugated or Alexa Flour 594-conjugated antibodies, raised in
goat and directed against immunoglobulins of the species used to raise the
primary antibody, were used for detection of the bound primary antibodies
(1:200, 1 h). Between each step the cells were carefully rinsed with PBS. A
light-scanning microscope was used to examine the cells.
Stimulation experiments
Cervical ﬁbroblasts were seeded on 12-well cell culture plates and grown until
conﬂuence, usually after 3 days. Cells were stimulated for 18 h with CRH
(Sigma) at concentrations ranging between 10
26 and 10
213 M and non-
stimulated control cells were cultured in parallel. All concentrations were per-
formed in duplicate. Media samples were collected and frozen until analysis.
MMP-1, MMP-3 and MMP-9 were quantiﬁed using ELISA as described
earlier. Quantiﬁcation of IL-8 was performed employing IMMULITE Auto-
mated Analyser (Diagnostic Products Corp., Los Angeles, CA, USA), using
thecommercially availableimmulite chemiluminescent enzymeimmunometric
assay (Immulite
w, Diagnostic Products Corp.) according to the manufacturer’s
instructions. The sensitivity of the assay was 2 pg/ml. The measured MMP-1,
MMP-3 and IL-8 concentrations were normalized to the total amount of
protein in corresponding cell layer, as determined using a BCA protein assay
kit (Pierce Chemical Co.).
Statistical analysis
Comparisons between two independent groups were performed utilizing the
Mann–Whitney U-test. When more than two groups were compared, the
Kruskal–Wallis test was applied, followed by multiple comparison with
Bonferroni–Dunn correction. For the comparison of the results in the stimu-
lation experiments, the Friedman ANOVA and Kendall’s concordance and
the Wilcoxon matched pair test were employed. In all cases, a P-value of
,0.05 was considered to be statistically signiﬁcant. All calculations were per-
formed with the STATISTICA 8.0 software (StatSoft Inc, Tulsa, OK, USA).
Results
The mRNA expression of MMP-1, -3, -8 and -9
in the cervical tissue
The mRNA expression of MMP-1, MMP-3 and MMP-9 was signiﬁ-
cantly higher in the term labor compared with term not in labor group
(Fig. 1A, B and D). The preterm labor group showed a similar pattern
and this difference reached statistical signiﬁcance for MMP-3 and
MMP-9. There were no signiﬁcant differences between the preterm
and respective term control groups. There were no differences
between the groups in MMP-8 mRNA expression and the results were
the same with two different Taqman
w gene expression assays (Fig. 1C).
Protein levels of MMPs in the cervical tissue
MMP-8 and MMP-9 were detected in all the samples. The laboring
groups had higher concentrations of MMP-8 and MMP-9, where the
difference was statistically signiﬁcant between the term in labor and
not in labor groups (Fig. 2). There were no signiﬁcant differences
between the preterm and respective term control groups.
The concentrations of MMP-1 and MMP-3 were generally low in
all the samples. MMP-1 was below detection limit in 25 samples
and MMP-3 was undetected in 9 samples. There were no signiﬁcant
differences in MMP-1 and MMP-3 concentrations between the
groups (data not shown).
Stimulation of cervical ﬁbroblasts
Cell cultures from preterm and term cervical biopsies stained posi-
tively for all three ﬁbroblast markers (Fig. 3).
Table II. Assay IDs and GenBank accession number for gene expression
assays used for real-time RT–PCR.
Gene Assay ID GenBank accession number
MMP-1 Hs00233958_m1 NM_002421.2
MMP-3 Hs00233962_m1 NM_002422.3
MMP-8
a Hs01029057_m1 NM_002424.1
MMP-8
a Hs00233972_m1 NM_002424.1
MMP-9 Hs00234579_m1 NM_004994.2
18s
b 4319413E X03205.1
b-actin
b 4352935E NM_001101.2
aTwo different expression assays were used for mRNA detection of MMP-8;
b18s and b-actin were used as endogenous controls.
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samples of cervical ﬁbroblasts. MMP-9 was not detected in any of
the samples.
CRH signiﬁcantly increased the secretion of IL-8 from the term and
preterm cervical ﬁbroblasts at concentrations 10
27–10
26 and 10
28,
10
26 M, respectively, compared with controls (Fig. 4A). The levels
of MMP-1 and MMP-3 were not signiﬁcantly changed by CRH
(Fig. 4B and C).
Furthermore, preterm and term cervical ﬁbroblasts showed different
secretion patterns of IL-8, MMP-1 and MMP-3. This difference was
statistically signiﬁcant when the whole preterm group was compared
with the term group. The secretion of IL-8 and MMP-1 was higher
in the preterm cervical ﬁbroblasts (P , 0.001 and ,0.05, respect-
ively). However, MMP-3 secretion was higher in the term cervical
ﬁbroblasts (P , 0.001) (Fig. 4A–C).
Discussion
In the present study, we have demonstrated for the ﬁrst time, that the
mRNA and protein expression of several MMPs increase in cervix
both at preterm and term labor. This ﬁnding together with our earlier
studies on CRH and cytokines in preterm cervix (Tornblom et al.,
2005b; Klimaviciute et al., 2006) indicates that preterm cervical ripen-
ing is the same inﬂammatory process as the cervical ripening at term.
In this study, we also analyzed the effect of CRH on the secretion of
MMPsandIL-8inthe cervical ﬁbroblasts. Toour knowledge,thisisthe
ﬁrst such kind of study on the preterm and term cervical ﬁbroblasts. We
have shown that CRH increased the secretion of IL-8 in both preterm
and term cervical ﬁbroblasts, but did not affect the secretion of
MMP-1 and MMP-3. MMP-9 was not detected in the culture
medium,which conﬁrms the earlier studies thatMMP-9 isnot produced
by cervical ﬁbroblasts (Ledingham et al., 1999; Stygar et al., 2002).
IL-8 is an important mediator of cervical ripening (Osmers et al.,
1995; Sennstrom et al., 1997). The fact that CRH and its receptors
are localized in the cervix (Klimaviciute et al., 2006) and that it has
an effect on IL-8 secretion from cervical ﬁbroblasts points towards
the possible role of CRH in the process of the cervical ripening.
Several studies have shown that CRH can stimulate the production of
proinﬂammatory cytokines in different cells (Angioni et al., 1993;
Yang et al., 2005; Wang et al., 2007), although some studies present
contradicting results (Angioni et al., 1993; Sehringer et al., 2000).
The possible mechanism by which CRH induces IL-8 production in
the cervical ﬁbroblasts could be a selective activation of the p38/
MAPK signaling pathway (Wang et al., 2007). However, CRH could
be involved in several different signaling pathways, like reactive
oxygen intermediates (Yang et al., 2005) or the NF-kB signaling
pathway (Zhao and Karalis, 2002; Zbytek et al., 2004).
The results on the secretion of MMP-1 and MMP-3 from cervical
ﬁbroblasts contradict the ﬁndings by Li and Challis (2005). Li and
Challis showed an induced secretion of MMP-9 by CRH in the cell
cultures from human placenta and fetal membranes. The explanation
for this contradiction could be that the cell cultures were established
from different tissues. Furthermore, different MMPs were analyzed.
However, cytokines are known to stimulate the production of MMPs
(Ito et al., 1991; Imada et al., 1997a, b; Oner et al., 2008), so it
would be logical to expect an elevation of MMP-1 and MMP-3
levels when there is an increased secretion of IL-8. One possible
explanation could be that even if the levels of IL-8 increase under
the action of CRH, the concentration might still be too low to
induce secretion of MMPs. Another explanation may be that IL-8
can induce the activity of MMPs (Thirumangalakudi et al., 2007)
with no effect on the total concentration of MMPs.
One interesting ﬁnding of this study is that preterm and term cervi-
cal ﬁbroblasts show different secretion patterns of IL-8, MMP-1 and
MMP-3, where IL-8 and MMP-1 are secreted at higher levels in
preterm and MMP-3 in term cervical ﬁbroblasts. In our unpublished
Figure 1: The mRNA expression of MMP-1 (A), MMP-3 (B), MMP-8 (C) and MMP-9 (D) in the cervical tissue.
CT, the threshold cycle at which an increase in reporter ﬂuorescence above the baseline signal is ﬁrst detected. The mRNA levels are normalized using geometric
mean (GM) of two endogenous controls (18s and b-actin). The studied groups are: preterm labor (PTL), preterm not in labor (PTnotL), term labor (TL), term not in
labor (TnotL). The box represents median value with 25–75% of all data falling within the box. The whiskers extend to the non-outlier range. The outliers are
marked as circles. The number of samples analyzed in each group is shown under the group name. Statistically signiﬁcant differences are indicated above the plots.
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duction in preterm and term cervical ﬁbroblasts. These ﬁndings indi-
cate that cervical ﬁbroblasts at preterm and term vaginal delivery may
have different phenotypes. However, in our studies, we were not able
to show any differences in the concentrations of cytokines or MMPs in
the preterm cervical tissue compared with term. One explanation for
this could be that we have many different cells producing MMPs
and IL-8 in the cervical tissue, like leukocytes, cervical smooth
muscle cells and macrophages. The clinical signiﬁcance of different
secretion patterns of IL-8, MMP-1 and MMP3 in preterm and term
cervical ﬁbroblasts still needs to be elucidated.
A notable observation is that MMP-1 was higher in preterm cervical
ﬁbroblasts, whereas MMP-3 was higher at term. MMP-1 and MMP-3
have different substrates in the tissue: MMP-1 breaks down ﬁbrillar
and non-ﬁbrillar collagens, whereas MMP-3 cleaves proteoglycans,
ﬁbronectine, gelatins, collagen IV and V (Hulboy et al., 1997).
Earlier studies have shown some differences between MMP-1 and
MMP-3 in amniotic ﬂuid. MMP-1, but not MMP-3, concentrations
increase in amniotic ﬂuid with advancing gestational age. Spon-
taneous parturition at term and preterm is associated with signiﬁcant
increase in amniotic ﬂuid concentrations of MMP-3, but not MMP-1
(Maymon et al., 2000; Park et al., 2003).
The main strength of this study is that human material was used. We
have well-deﬁned patient groups both in labor and not in labor at
preterm and at term. Cervical biopsies are extremely hard to obtain
especially in relation to preterm delivery, which is the reason why so
few studies are conducted on the human preterm cervix. Our group
has applied this sampling procedure for almost 30 years to obtain cer-
vical tissue samples including squamous and cylindrical epithelium,
vessels, glands and ECM. The study also includes both analysis in
the cervical tissue and experiments on the cervical ﬁbroblasts in vitro.
A weakness of the study could be the relatively small size of the
groups investigated. This could be explained by the invasive sampling
procedure, which is extremely hard to coordinate with delivery and
renders it difﬁcult to get a large number of samples. Nevertheless,
important differences between the groups are still possible to detect
as we have seen in our earlier studies (Sennstrom et al., 1997,
2003). Secondly, the use of different passages of cervical ﬁbroblasts
could be seen as disadvantage. However, we have seen a stable pheno-
type until passage 8 in our earlier studies of cervical ﬁbroblasts
(Malmstrom et al., 2007). In this study, we have determined the
levels of total MMPs. It is possible that the results could have been
different if we had examined the active forms of MMPs. Prostaglandin
E2, for instance, induces activation of MMP-3, but does not affect
MMP-3 total protein in the rat cervix (Chien et al., 2005). However,
proteolytic activity of MMP-1 and MMP-3 follows the same pattern
as total protein levels in human decidual cells (Oner et al., 2008).
We have chosen to perform analysis of the total MMPs, as it was
not possible to perform analysis of both total and active forms in
this study because of the shortage of material. Moreover, the lower
levels of active MMPs could be undetectable (Li and Challis, 2005).
In conclusion, the current study shows that spontaneous parturition
at preterm and at term is associated with elevated mRNA and protein
levels of MMPs in the cervical tissue. However, different secretion
patterns of IL-8, MMP-1 and MMP-3 in preterm and term cervical
ﬁbroblasts indicate that they might have different phenotypes.Further-
more, CRH stimulates the secretion of IL-8 both in preterm and term
cervical ﬁbroblasts, which suggests that CRH could be involved in the
Figure 2: Protein levels of MMP-8 (A) and MMP-9 (B) in the cervical tissue.
The protein levels are normalized to the total amount of protein. The studied
groups are: preterm labor (PTL), preterm not in labor (PTnotL), term labor
(TL), term not in labor (TnotL). The box represents median value with 25–
75% of all data falling within the box. The whiskers extend to the non-outlier
range. The outliers are marked as circles. The number of samples analyzed in
each group is shown under the group name. Statistically signiﬁcant differences
are indicated above the plots.
Figure 3: Immunostaining of cell cultures for ﬁbroblast markers.
Cell cultures from preterm (left column) and term (right column) cervical biop-
sies were immunostained using antibodies directed against vimentin (A and B),
ﬁbroblast surface marker 1B10 (C and D) and prolyl-4-hydroxylase beta
(E and F).
CRH effect on preterm and term cervical ﬁbroblasts
645process of cervical ripening. Further studies are still needed to eluci-
date the signiﬁcance of these ﬁndings.
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